Procalcitonin (PCT) has emerged as a significant biomarker for bacterial infections and has shown potential in guiding antibiotic therapy, particularly within the context of antimicrobial stewardship programs. This article explores the role of procalcitonin in hospitalized patients with seasonal influenza, focusing on its utility as an antimicrobial stewardship tool. By analyzing the current literature, this study investigates how PCT levels can differentiate between bacterial and viral infections, thereby optimizing antibiotic use, reducing unnecessary prescriptions, and ultimately combating antibiotic resistance. The findings indicate that PCT-guided therapy can effectively improve patient outcomes, decrease hospital costs, and support the global initiative for responsible antibiotic use.
HTML PDFShare this article
Journal of Infectious Diseases and Medicine received 59 citations as per Google Scholar report
